Cecilie L. Bager
- Molecular Biology
- Oncology top 10%
- Cancer Research top 10%
- Epidemiology
- Hepatology top 5%
- Co-authors
- M.A. KarsdalNicholas WillumsenDiana Julie LeemingAnne‐Christine Bay‐JensenMette Juul NielsenVictoria SmithDavid DornanJannie Marie Bülow Sand
- Topics
- Protease and Inhibitor Mechanisms (14 papers)Peptidase Inhibition and Analysis (10 papers)Cell Adhesion Molecules Research (5 papers)
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
Cecilie L. Bager
35 papers receiving 932 citations
Peers
Comparison fields: 5 of 96
- Molecular Biology 270
- Oncology 267
- Cancer Research 201
- Epidemiology 194
- Hepatology 164
Countries citing papers authored by Cecilie L. Bager
This map shows the geographic impact of Cecilie L. Bager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilie L. Bager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilie L. Bager more than expected).
Fields of papers citing papers by Cecilie L. Bager
This network shows the impact of papers produced by Cecilie L. Bager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilie L. Bager. The network helps show where Cecilie L. Bager may publish in the future.
Co-authorship network of co-authors of Cecilie L. Bager
This figure shows the co-authorship network connecting the top 25 collaborators of Cecilie L. Bager. A scholar is included among the top collaborators of Cecilie L. Bager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilie L. Bager. Cecilie L. Bager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 4 | |
| 3 | 1 | |
| 4 | 58 | |
| 5 | 18 | |
| 6 | 17 | |
| 7 | 6 | |
| 8 | 4 | |
| 9 | 30 | |
| 10 | 17 | |
| 11 | 21 | |
| 12 | 17 | |
| 13 | 1 | |
| 14 | 5 | |
| 15 | 45 | |
| 16 | 45 | |
| 17 | 33 | |
| 18 | 12 | |
| 19 | 23 | |
| 20 | 57 |
About Cecilie L. Bager
Cecilie L. Bager is a scholar working on Cancer Research, Immunology and Allergy and Oncology, having authored 35 papers that have together received 937 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (14 papers), Peptidase Inhibition and Analysis (10 papers) and Cell Adhesion Molecules Research (5 papers). The work is most often cited by research in Hepatology (164 citations), Immunology and Allergy (99 citations) and Cancer Research (201 citations). Cecilie L. Bager has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include M.A. Karsdal, Nicholas Willumsen, Diana Julie Leeming, Anne‐Christine Bay‐Jensen, Mette Juul Nielsen, Victoria Smith, David Dornan, Jannie Marie Bülow Sand, Tina Manon‐Jensen and Federica Genovese. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.